Navigation Links
Novel Test Promises to Save Babies from ‘testing’ Tims

Pre-eclampsia, an extremely undesirable condition in pregnant woman,// poses a grave threat to both mother and child. The condition is said to claim the lives of nearly 600 babies each year in Britain. Now, scientists have devised a new diagnostic evaluation for pregnant women, capable of detecting the condition early and saving lives.

The research team from University College London said that the presence of a particular protein in the urine of a pregnant woman is an indication of the woman’s propensity to develop pre-eclampsia.

Pre eclampsia is a condition in which a defective placenta causes the blood pressure to rise abnormally leading to complications and kidney problems in the pregnant mother. Most often, the symptoms do not manifest early in the pregnancy, leaving women with very little choice, other than a premature delivery.

During the study, researchers examined the urine of 27 women who developed pre-eclampsia and 47 others who did not develop the condition. The tests revealed that a particular protein called inositol phosphoglygan P-type was markedly higher in women who developed the condition. The researchers went a step further suggesting that the protein could be the contaminant in the system, triggering the condition. If that is the case, then treatment measures could be directed to quash the effects of the protein, saving women and their babies from difficulties.

Professor Thomas W Rademacher from UCL said: “Being able to predict the onset of this disease has been the single greatest challenge in obstetric medicine. Pre-eclampsia is the most common of the serious complications that can occur during pregnancy. This means that by way of a simple urine test during pregnancy, we can identify which women are most at risk of developing the condition.”


SV
'"/>




Page: 1

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers ... back pain with a reputable physician in their area, announces the launch of a ... information for patients who are looking for reputable physicians to help them with back ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... addition of predictive analytics to its patient care management module. Using this new ... before a patient has been initiated on continuous positive airway pressure (CPAP), oral, ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® ... introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky ... horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG ... Your Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national ... which pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use kit ...
(Date:4/24/2017)... ... 2017 , ... Ridgecrest Herbals makes it a point to lead the Utah ... and support renewable energy. They believe this is a crucial part of their mission ... health issues, and maintain that destroying the environment in the pursuit of profit is ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 Cardiology ... during the projected period The Cardiology Devices segment ... more than US$ 15 Mn in 2018 over 2017. By ... reach a market valuation close to US$ 700 Mn, expanding ... Cardiology Devices segment dominated the Asia Pacific ...
Breaking Medicine Technology: